Vaxzevria (AstraZeneca Oxford - ChAdOx1 nCoV-19) - living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID-19 severe or critically

	COVID-19 prophylaxis (excluding children)
Vaxzevria (AstraZeneca Oxford - ChAdOx1 nCoV-19)	COV005 ComFluCOV ... ChAdOx1 phase 3 ...

33 studies excluded by filtering options 0

4992	Candidate COVID-19 Vaccine (COV001), 2020	2	1	0	excluded		risk of bias not avaialble
5682	AstraZeneca Oxford COV003 phase 3, 0	1	1	0			risk of bias not avaialble
5810	AstraZeneca phase 3 US (D8110C00001), 2021	1	1	0			risk of bias not avaialble
6103	Folegatti, 2020	0	1	0	selection pending
6444	Barrett, 2020	2	0	0	excluded		risk of bias not avaialble
6664	Scotland cohort, 0	1	10	0		not a RCT	risk of bias not avaialble
6965	Bernal (PHE, 19th February 2021), 2021	1	13	0		not a RCT	risk of bias not avaialble
6975	Corchado-Garcia, 2021	0	13	0	selection pending
7012	Pottegard, 2021	1	15	4		not a RCT	high risk of bias
7017	John, 2021	0	0	0	selection pending
7022	Bernal, 0	1	13	0		not a RCT	risk of bias not avaialble
7939	Com-COV, 2021	1	1	0			risk of bias not avaialble
8252	Edward (Vaxzevria), 2021	1	13	4		not a RCT	high risk of bias
8267	Burn (Vaxzevria), 2021	1	13	4		not a RCT	high risk of bias
9070	Tobaiqy M, 2021	2	32	0	excluded	not a RCT	risk of bias not avaialble
9216	Sultan, 2022	0	12	0	selection pending
9221	Bonelli, 2022	0	0	0	selection pending
9232	Com-COV2, 2022	1	1	0			risk of bias not avaialble
9234	Asano, 2022	1	1	0			risk of bias not avaialble
9244	Richardson, 2022	0	0	0	selection pending
9268	Nguyen, 2021	0	11	0	selection pending
9296	Hippisley-Cox, 2021	1	12	0		not a RCT	risk of bias not avaialble
9297	Simpson (ChAdOx1), 2021	1	12	0		not a RCT	risk of bias not avaialble
9313	EPIPHARE (Vaxzevria), 2022	1	12	0		not a RCT	risk of bias not avaialble
9356	AstraZeneca Oxford pooled analysis (COV003, COV001, COV002, COV005)_safety, 2020	1	1	0			risk of bias not avaialble
9360	Husby (Astra), 2021	1	12	0		not a RCT	risk of bias not avaialble
9370	Kanokudom, 2022	0	0	0	selection pending
9376	Nanthapisal, 2022	2	1	0	excluded		risk of bias not avaialble
9467	Clemens, 2021	0	10	0	selection pending
9492	Patone, 2021	1	12	0		not a RCT	risk of bias not avaialble
9614	Rearte, 2022	0	12	0	selection pending
10189	AstraZeneca phase 3 US (D8110C00001) 6 month follow up, 2021	1	1	0			risk of bias not avaialble
10190	Valim, 2022	0	0	0	selection pending